▶ 調査レポート

急性腎不全治療薬の世界市場:市場規模・現状・予測

• 英文タイトル:Global Acute Renal Failure Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。急性腎不全治療薬の世界市場:市場規模・現状・予測 / Global Acute Renal Failure Therapeutics Market Size, Status and Forecast 2019-2025 / QYR9ST04369資料のイメージです。• レポートコード:QYR9ST04369
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、急性腎不全治療薬の世界市場について調査・分析し、急性腎不全治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(重炭酸ナトリウム、N-アセチルシステイン、スタチン、その他)、用途別(病院、診療所、外来手術センター)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の急性腎不全治療薬市場動向
・主要企業別マーケットシェア
・急性腎不全治療薬の種類別市場規模2014-2019
(重炭酸ナトリウム、N-アセチルシステイン、スタチン、その他)
・急性腎不全治療薬の用途別市場規模2014-2019
(病院、診療所、外来手術センター)
・急性腎不全治療薬の北米市場:主要企業・種類別/用途別市場規模
・急性腎不全治療薬のヨーロッパ市場:主要企業・種類別/用途別市場規模
・急性腎不全治療薬の中国市場:主要企業・種類別/用途別市場規模
・急性腎不全治療薬の日本国内市場:主要企業・種類別/用途別市場規模
・急性腎不全治療薬の東南アジア市場:主要企業・種類別/用途別市場規模
・急性腎不全治療薬のインド市場:主要企業・種類別/用途別市場規模
・急性腎不全治療薬の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Baxter、Teva Pharmaceutical、Pfizer、Novartis、Eisai Pharmaceuticals)
・急性腎不全治療薬の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body.Acute renal failure associated with mortality, organ dysfunctions, and development of chronic kidney diseases. It also has long term and short term issues in functional status and leads to increased healthcare expenditure. The incidence of acute renal failure is high and it most common in elderly, diabetic and obese. Etiology is also high and may be secondary to infections such as dengue, malaria, and leptospirosis. The proportion of patients receiving treatment for acute renal failure depends on the economies of the countries. Renal failure is more common in low-middle income countries followed by high-income countries. Because increasing burden of acute renal failure, professional organizations and societies are disseminating information effectively to increase awareness. American Society of Nephrology and International society of nephrology are professional organization involved in fostering education and research. Acute renal failure is common globally and imposes high health care burden. All these factors act as drivers in the robust growth of acute renal failure therapeutic.
In 2018, the global Acute Renal Failure Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Acute Renal Failure Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Renal Failure Therapeutics development in United States, Europe and China.

The key players covered in this study
Baxter
Teva Pharmaceutical
Pfizer
Novartis
Eisai Pharmaceuticals

Market segment by Type, the product can be split into
Sodium Bicarbonates
N-Acetyl Cysteine
Statins
Others

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Acute Renal Failure Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Acute Renal Failure Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Acute Renal Failure Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Acute Renal Failure Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Sodium Bicarbonates
1.4.3 N-Acetyl Cysteine
1.4.4 Statins
1.4.5 Others
1.5 Market by Application
1.5.1 Global Acute Renal Failure Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Acute Renal Failure Therapeutics Market Size
2.2 Acute Renal Failure Therapeutics Growth Trends by Regions
2.2.1 Acute Renal Failure Therapeutics Market Size by Regions (2014-2025)
2.2.2 Acute Renal Failure Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Acute Renal Failure Therapeutics Market Size by Manufacturers
3.1.1 Global Acute Renal Failure Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Acute Renal Failure Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Acute Renal Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Acute Renal Failure Therapeutics Key Players Head office and Area Served
3.3 Key Players Acute Renal Failure Therapeutics Product/Solution/Service
3.4 Date of Enter into Acute Renal Failure Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Acute Renal Failure Therapeutics Market Size by Type (2014-2019)
4.2 Global Acute Renal Failure Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Acute Renal Failure Therapeutics Market Size (2014-2019)
5.2 Acute Renal Failure Therapeutics Key Players in United States
5.3 United States Acute Renal Failure Therapeutics Market Size by Type
5.4 United States Acute Renal Failure Therapeutics Market Size by Application

6 Europe
6.1 Europe Acute Renal Failure Therapeutics Market Size (2014-2019)
6.2 Acute Renal Failure Therapeutics Key Players in Europe
6.3 Europe Acute Renal Failure Therapeutics Market Size by Type
6.4 Europe Acute Renal Failure Therapeutics Market Size by Application

7 China
7.1 China Acute Renal Failure Therapeutics Market Size (2014-2019)
7.2 Acute Renal Failure Therapeutics Key Players in China
7.3 China Acute Renal Failure Therapeutics Market Size by Type
7.4 China Acute Renal Failure Therapeutics Market Size by Application

8 Japan
8.1 Japan Acute Renal Failure Therapeutics Market Size (2014-2019)
8.2 Acute Renal Failure Therapeutics Key Players in Japan
8.3 Japan Acute Renal Failure Therapeutics Market Size by Type
8.4 Japan Acute Renal Failure Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Acute Renal Failure Therapeutics Market Size (2014-2019)
9.2 Acute Renal Failure Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Acute Renal Failure Therapeutics Market Size by Type
9.4 Southeast Asia Acute Renal Failure Therapeutics Market Size by Application

10 India
10.1 India Acute Renal Failure Therapeutics Market Size (2014-2019)
10.2 Acute Renal Failure Therapeutics Key Players in India
10.3 India Acute Renal Failure Therapeutics Market Size by Type
10.4 India Acute Renal Failure Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Acute Renal Failure Therapeutics Market Size (2014-2019)
11.2 Acute Renal Failure Therapeutics Key Players in Central & South America
11.3 Central & South America Acute Renal Failure Therapeutics Market Size by Type
11.4 Central & South America Acute Renal Failure Therapeutics Market Size by Application

12 International Players Profiles
12.1 Baxter
12.1.1 Baxter Company Details
12.1.2 Company Description and Business Overview
12.1.3 Acute Renal Failure Therapeutics Introduction
12.1.4 Baxter Revenue in Acute Renal Failure Therapeutics Business (2014-2019)
12.1.5 Baxter Recent Development
12.2 Teva Pharmaceutical
12.2.1 Teva Pharmaceutical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Acute Renal Failure Therapeutics Introduction
12.2.4 Teva Pharmaceutical Revenue in Acute Renal Failure Therapeutics Business (2014-2019)
12.2.5 Teva Pharmaceutical Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Acute Renal Failure Therapeutics Introduction
12.3.4 Pfizer Revenue in Acute Renal Failure Therapeutics Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Acute Renal Failure Therapeutics Introduction
12.4.4 Novartis Revenue in Acute Renal Failure Therapeutics Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Eisai Pharmaceuticals
12.5.1 Eisai Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Acute Renal Failure Therapeutics Introduction
12.5.4 Eisai Pharmaceuticals Revenue in Acute Renal Failure Therapeutics Business (2014-2019)
12.5.5 Eisai Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Acute Renal Failure Therapeutics Key Market Segments
Table Key Players Acute Renal Failure Therapeutics Covered
Table Global Acute Renal Failure Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Acute Renal Failure Therapeutics Market Size Market Share by Type 2014-2025
Figure Sodium Bicarbonates Figures
Table Key Players of Sodium Bicarbonates
Figure N-Acetyl Cysteine Figures
Table Key Players of N-Acetyl Cysteine
Figure Statins Figures
Table Key Players of Statins
Figure Others Figures
Table Key Players of Others
Table Global Acute Renal Failure Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Acute Renal Failure Therapeutics Report Years Considered
Table Global Acute Renal Failure Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Acute Renal Failure Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Acute Renal Failure Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Acute Renal Failure Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Acute Renal Failure Therapeutics Market Share by Regions 2014-2019
Figure Global Acute Renal Failure Therapeutics Market Share by Regions 2014-2019
Figure Global Acute Renal Failure Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Acute Renal Failure Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Acute Renal Failure Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Acute Renal Failure Therapeutics Market Share by Manufacturers in 2018
Table Global Acute Renal Failure Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Acute Renal Failure Therapeutics Product/Solution/Service
Table Date of Enter into Acute Renal Failure Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Acute Renal Failure Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Acute Renal Failure Therapeutics Market Size Share by Type (2014-2019)
Figure Global Acute Renal Failure Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Acute Renal Failure Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Acute Renal Failure Therapeutics Market Size Share by Application (2014-2019)
Figure Global Acute Renal Failure Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Acute Renal Failure Therapeutics Revenue Market Share by Application in 2018
Figure United States Acute Renal Failure Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Acute Renal Failure Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Acute Renal Failure Therapeutics Market Share (2018-2019)
Table United States Acute Renal Failure Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Acute Renal Failure Therapeutics Market Share by Type (2014-2019)
Table United States Acute Renal Failure Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Acute Renal Failure Therapeutics Market Share by Application (2014-2019)
Figure Europe Acute Renal Failure Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Acute Renal Failure Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Acute Renal Failure Therapeutics Market Share (2018-2019)
Table Europe Acute Renal Failure Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Acute Renal Failure Therapeutics Market Share by Type (2014-2019)
Table Europe Acute Renal Failure Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Acute Renal Failure Therapeutics Market Share by Application (2014-2019)
Figure China Acute Renal Failure Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Acute Renal Failure Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Acute Renal Failure Therapeutics Market Share (2018-2019)
Table China Acute Renal Failure Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Acute Renal Failure Therapeutics Market Share by Type (2014-2019)
Table China Acute Renal Failure Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Acute Renal Failure Therapeutics Market Share by Application (2014-2019)
Figure Japan Acute Renal Failure Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Acute Renal Failure Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Acute Renal Failure Therapeutics Market Share (2018-2019)
Table Japan Acute Renal Failure Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Acute Renal Failure Therapeutics Market Share by Type (2014-2019)
Table Japan Acute Renal Failure Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Acute Renal Failure Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Acute Renal Failure Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Acute Renal Failure Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Acute Renal Failure Therapeutics Market Share (2018-2019)
Table Southeast Asia Acute Renal Failure Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Acute Renal Failure Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Acute Renal Failure Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Acute Renal Failure Therapeutics Market Share by Application (2014-2019)
Figure India Acute Renal Failure Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Acute Renal Failure Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Acute Renal Failure Therapeutics Market Share (2018-2019)
Table India Acute Renal Failure Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Acute Renal Failure Therapeutics Market Share by Type (2014-2019)
Table India Acute Renal Failure Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Acute Renal Failure Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Acute Renal Failure Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Acute Renal Failure Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Acute Renal Failure Therapeutics Market Share (2018-2019)
Table Central & South America Acute Renal Failure Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Acute Renal Failure Therapeutics Market Share by Type (2014-2019)
Table Central & South America Acute Renal Failure Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Acute Renal Failure Therapeutics Market Share by Application (2014-2019)
Table Baxter Company Details
Table Baxter Revenue in Acute Renal Failure Therapeutics Business (2014-2019) (Million US$)
Figure Baxter Revenue Growth Rate in Acute Renal Failure Therapeutics Business (2014-2019)
Table Baxter Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Acute Renal Failure Therapeutics Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Acute Renal Failure Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Acute Renal Failure Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Acute Renal Failure Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Acute Renal Failure Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Acute Renal Failure Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Eisai Pharmaceuticals Company Details
Table Eisai Pharmaceuticals Revenue in Acute Renal Failure Therapeutics Business (2014-2019)(Million US$)
Figure Eisai Pharmaceuticals Revenue Growth Rate in Acute Renal Failure Therapeutics Business (2014-2019)
Table Eisai Pharmaceuticals Recent Development
Table Global Acute Renal Failure Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Acute Renal Failure Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Acute Renal Failure Therapeutics Market Size Share by Regions in 2025
Figure United States Acute Renal Failure Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Acute Renal Failure Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Acute Renal Failure Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Acute Renal Failure Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Acute Renal Failure Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Acute Renal Failure Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Acute Renal Failure Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Acute Renal Failure Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Acute Renal Failure Therapeutics Market Size by Product (2019-2025)
Figure Global Acute Renal Failure Therapeutics Market Size by Product in 2025
Table Global Acute Renal Failure Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Acute Renal Failure Therapeutics Market Size by Application (2019-2025)
Figure Global Acute Renal Failure Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources